14158 Results (Page 442 of 567)
All Market Research Reports
Australia Liver Diseases Therapeutics Market Analysis
By 2030, it is anticipated that the Australia Liver Disease Therapeutics market will reach a value of $483 Mn from $277 Mn in 2022, growing at a CAGR of 7.2% during 2022-2030. Liver Disease Therapeutics in Australia is dominated by a few domestic pharmaceutical companies such as Aspen Pharmacare Australia, Mayne Pharma, and Phebra. The Liver Disease Therapeutics market in Australia is segmented into different types of disease and different therapy types. Some of the major factors affecting the Australian Liver Disease Therapeutics market are the growing prevalence of liver diseases and unhealthy and dynamic lifestyles.
Thailand Oncology Clinical Trials Market Analysis
Thailand’s oncology clinical trials market is projected to grow from $15.2 Mn in 2022 to $23.9 Mn by 2030, registering a CAGR of 5.84% during the forecast period of 2022-30. The market will be driven by the rising incidence of cancer along with the country's strategic position and inexpensive clinical trial costs. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer Inc., FHoffmann-La Roche Ltd & Siam Bioscience Co., Ltd.
Singapore Oncology Clinical Trials Market Analysis
Singapore's oncology clinical trials market is projected to grow from $15.2 Mn in 2022 to $24.4 Mn by 2030, registering a CAGR of 6.1% during the forecast period of 2022-30. The market will be driven by the rising number of cancer cases and a favorable regulatory climate for clinical trials. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer Inc., Novartis International AG & Aslan Pharmaceuticals.
Philippines Oncology Clinical Trials Market Analysis
The Philippines oncology clinical trials market is projected to grow from $27.8 Mn in 2022 to $44.4 Mn by 2030, registering a CAGR of 6% during the forecast period of 2022-30. The market will be driven by the growing cancer burden, favorable regulatory environment, and cheaper costs. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer Inc., Novartis International AG & AstraZeneca plc.
Japan Oncology Clinical Trials Market Analysis
Japan's oncology clinical trials market is projected to grow from $0.79 Bn in 2022 to $1.25 Bn by 2030, registering a CAGR of 6% during the forecast period of 2022-30. The market will be driven by a well-established healthcare system, advanced infrastructure, and a high prevalence of cancer. The market is segmented by phase, by study design & by indication. Some of the major players include Novartis International AG, Chugai Pharmaceutical Co., Ltd. & Ono Pharmaceutical Co., Ltd.
UK Liver Diseases Therapeutics Market Analysis
By 2030, it is anticipated that the UK Liver Disease Therapeutics market will reach a value of $803 Mn from $600 Mn in 2022, growing at a CAGR of 3.7% during 2022-2030. Liver Disease Therapeutics in the UK is dominated by a few domestic pharmaceutical companies such as Intercept Pharmaceuticals, Gilead Sciences, AstraZeneca and Shire. The Liver Disease Therapeutics market in the UK is segmented into different types of disease and different therapy types. Some of the major factors affecting the UK Liver Disease Therapeutics market are the growing prevalence of liver diseases and unhealthy and dynamic lifestyles.
Brazil Oncology Clinical Trials Market Analysis
Brazil's oncology clinical trials market is projected to grow from $316.3 Mn in 2022 to $523.4 Mn by 2030, registering a CAGR of 6.5% during the forecast period of 2022-30. The market will be driven by the increased investment in healthcare and research and the rise in oncology clinical trials owing to rising cancer cases in Brazil. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer Inc., Novartis International AG & Eurofarma Laboratórios S.A.
Australia Oncology Clinical Trials Market Analysis
Australia's oncology clinical trials market is projected to grow from $151.8 Mn in 2022 to $260.8 Mn by 2030, registering a CAGR of 7% during the forecast period of 2022-30. The market will be driven by the rising investment in clinical research, increased patient education and engagement, and the development of new and innovative clinical trial designs. The market is segmented by phase, by study design & by indication. Some of the major players include Novartis International AG, AstraZeneca plc & Kazia Therapeutics Limited.
Turkey Liver Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Turkey Liver Cancer Therapeutics market will reach a value of $88.7 Mn from $23.4 Mn in 2022, growing at a CAGR of 18.1 % during 2022-2030. Liver Cancer Therapeutics in Turkey is dominated by a few domestic pharmaceutical companies such as Nobel İlaç, Mustafa Nevzat Pharmaceuticals and Deva Holding. The Liver Cancer Therapeutics market in Turkey is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Turkey Liver Cancer Therapeutics market are the growing prevalence of liver cancer and the high cost and side effects related to certain liver cancer therapies.
Thailand Liver Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Thailand Liver Cancer Therapeutics market will reach a value of $13.2 Mn from $3.52 Mn in 2022, growing at a CAGR of 17.9% during 2022-2030. Liver Cancer Therapeutics in Thailand is dominated by a few domestic pharmaceutical companies such as Siam Bioscience, Mega Lifesciences and Bangkok Hospital. The Liver Cancer Therapeutics market in Thailand is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Thailand Liver Cancer Therapeutics market are the growing prevalence of liver cancer and the high cost and side effects related to certain liver cancer therapies.
Tanzania Liver Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Tanzania Liver Cancer Therapeutics market will reach a value of $4.6 Mn from $1.2 Mn in 2022, growing at a CAGR of 18.5 % during 2022-2030. The Liver Cancer Therapeutics in Tanzania is dominated by a few domestic pharmaceutical companies such as Zenufa, MCL Pharmaceuticals and African Pharmaceutical. The Liver Cancer Therapeutics market in Tanzania is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Tanzania Liver Cancer Therapeutics market are the growing prevalence of liver cancer and the high cost and side effects related to certain liver cancer therapies.
UAE Oncology Clinical Trials Market Analysis
The UAE oncology clinical trials market is projected to grow from $63.3 Mn in 2022 to $104.7 Mn by 2030, registering a CAGR of 6.5% during the forecast period of 2022-30. The market will be driven by the rising rate of cancer in the UAE and investments in developing healthcare infrastructure and research capabilities to support the field. The market is segmented by phase, study design, and indication. Some of the major players include Pfizer Inc, FHoffmann-La Roche Ltd & Julphar
Spain Liver Diseases Therapeutics Market Analysis
By 2030, it is anticipated that the Spain Liver Disease Therapeutics market will reach a value of $644 Mn from $446 Mn in 2022, growing at a CAGR of 4.7% during 2022-2030. Liver Disease Therapeutics in Spain is dominated by a few domestic pharmaceutical companies such as Grifols, Faes Farma, and Laboratorios Rubió. The Liver Disease Therapeutics market in Spain is segmented into different types of disease and different therapy types. Some of the major factors affecting the Spain Liver Disease Therapeutics market are the growing prevalence of liver diseases and unhealthy and dynamic lifestyles.
Romania Oncology Clinical Trials Market Analysis
Romania's oncology clinical trials market is projected to grow from $36.7 Mn in 2022 to $57.4 Mn by 2030, registering a CAGR of 5.75% during the forecast period of 2022-30. The market will be driven by the country’s rising incidence of cancers and supportive regulatory environment. The market is segmented by phase, by study design & by indication. Some of the major players include Roche Holding AG, Pfizer Inc. & Biofarm SA.
South Korea Liver Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the South Korea Liver Cancer Therapeutics market will reach a value of $ 167.6 Mn from $42.81 Mn in 2022, growing at a CAGR of 18.6% during 2022-2030. Liver Cancer Therapeutics in South Korea is dominated by a few domestic pharmaceutical companies such as Green Cross Cell Corporation, Handok Pharmaceuticals and Yuhan Corporation. The Liver Cancer Therapeutics market in South Korea is segmented into different types of cancer and different therapy type. Some of the major factors affecting the South Korea Liver Cancer Therapeutics market are the growing prevalence of liver cancer and the high cost and side effects related to certain liver cancer therapies.
Italy Oncology Clinical Trials Market Analysis
Italy's oncology clinical trials market is projected to grow from $303.6 Mn in 2022 to $448.6 Mn by 2030, registering a CAGR of 5% during the forecast period of 2022-30. The market will be driven by the rising incidence of cancer in Italy & well-established research infrastructure and regulatory environment. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer Inc., Roche Holding AG & MolMed S.p.A.
India Oncology Clinical Trials Market Analysis
India's oncology clinical trials market is projected to grow from $230.1 Mn in 2022 to $441.8 Mn by 2030, registering a CAGR of 8.5% during the forecast period of 2022-30. The market will be driven by the rising prevalence of Oncological disorders, the availability of a large patient pool with various genetic profiles, and low-cost clinical trials. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer Inc., Sun Pharmaceutical Industries Ltd., Cadila Healthcare Ltd. & Cipla Ltd.
Germany Oncology Clinical Trials Market Analysis
Germany's oncology clinical trials market is projected to grow from $463 Mn in 2022 to $619.2 Mn by 2030, registering a CAGR of 3.7% during the forecast period of 2022-30. The market will be driven by the strong healthcare infrastructure, focus on personalized medicine, and experienced workforce. The market is segmented by phase, by study design & by indication. Some of the major players include Novartis AG, Roche Holding AG, Bayer AG & BioNTech SE.
France Oncology Clinical Trials Market Analysis
The France oncology clinical trials market is projected to grow from $347.9 Mn in 2022 to $494.7 Mn by 2030, registering a CAGR of 4.5% during the forecast period of 2022-30. The market will be driven by the rising prevalence of cancer cases, the modern healthcare system in the nation, and a supportive regulatory framework. The market is segmented by phase, by study design & by indication. Some of the major players include Roche Holding AG, Transgene & Ipsen.
Singapore Liver Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Singapore Liver Cancer Therapeutics market will reach a value of $13.4 Mn from $3.52 Mn in 2022, growing at a CAGR of 18.2 % during 2022-2030. The Liver Cancer Therapeutics in Singapore is dominated by a few domestic pharmaceutical companies such as Clearbridge BioMedics, A*STAR and ASLAN Pharmaceuticals. The Liver Cancer Therapeutics market in Singapore is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Singapore Liver Cancer Therapeutics market are the growing prevalence of liver cancer and the high cost and side effects related to certain liver cancer therapies.
China Oncology Clinical Trials Market Analysis
China's oncology clinical trials market is projected to grow from $1.02 Bn in 2022 to $1.75 Bn by 2030, registering a CAGR of 7% during the forecast period of 2022-30. The market will be driven by the rising incidence of cancer in the country and efforts to promote research, collaboration, and innovation. The market is segmented by phase, by study design & by indication. Some of the major players include Novartis AG, Roche Holding AG, Jiangsu Hengrui Pharmaceutical & Sino Biopharmaceutical.
Belgium Oncology Clinical Trials Market Analysis
The Belgium oncology clinical trials market is projected to grow from $27.8 Mn in 2022 to $42.7 Mn by 2030, registering a CAGR of 5.5% during the forecast period of 2022-30. The market will be driven by increasing demand for innovative cancer therapies and a growing focus on personalized medicine. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer Inc., Roche Holding AG & Galapagos NV.
Romania Liver Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Romania Liver Cancer Therapeutics market will reach a value of $31.6 Mn from $8.5 Mn in 2022, growing at a CAGR of 17.9 % during 2022-2030. Liver Cancer Therapeutics in Romania is dominated by a few domestic pharmaceutical companies such as Biofarm, Antibiotice and Fundeni Clinical Institute. The Liver Cancer Therapeutics market in Romania is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Romania Liver Cancer Therapeutics market are the growing prevalence of liver cancer and the high cost and side effects related to certain liver cancer therapies.
Poland Liver Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Poland Liver Cancer Therapeutics market will reach a value of $64.1 Mn from $17 Mn in 2022, growing at a CAGR of 18.1 % during 2022-2030. Liver Cancer Therapeutics in Poland is dominated by a few domestic pharmaceutical companies such as Polpharma Biologics, Adamed Group and Celon Pharma. The Liver Cancer Therapeutics market in Poland is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Poland Liver Cancer Therapeutics market are the growing prevalence of liver cancer and the high cost and side effects related to certain liver cancer therapies.
Nigeria Liver Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Nigeria Liver Cancer Therapeutics market will reach a value of $10.3 Mn from $2.6 Mn in 2022, growing at a CAGR of 18.6 % during 2022-2030. Liver Cancer Therapeutics in Nigeria is dominated by a few domestic pharmaceutical companies such as Swiss Pharma Nigeria, Fidson Healthcare and Neimeth. The Liver Cancer Therapeutics market in Nigeria is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Nigeria Liver Cancer Therapeutics market are the growing prevalence of liver cancer and the high cost and side effects related to certain liver cancer therapies.
